Close

Gilead Sciences (GILD) Misses Q1 EPS by 10c

April 28, 2016 4:05 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $3.03, $0.10 worse than the analyst estimate of $3.13. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $8.08 billion. Gilead Sciences reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings

Related Entities

Earnings